Pharmacogenetically determined treatment' influence Left Ventricular Mass Index (LVMI) in relation to polymorphisms of ACE, AGTR1, eNOS, PPAR-G2, ADRB1 genes in essential hypertensive (EAH) patients

Sydorchuk, L.; Amosova, K.M.; Sydorchuk, R.; Ursuliak, U.; Sydorchuk, I.

dc.contributor.author	Sydorchuk, L.
dc.contributor.author	Amosova, K.M.	en
dc.contributor.author	Sydorchuk, R.
dc.contributor.author	Ursuliak, U.
dc.contributor.author	Sydorchuk, I.
dc.date.accessioned	2015-05-20T05:37:44Z
dc.date.available	2015-05-20T05:37:44Z
dc.date.issued	2010
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/8880
dc.language.iso	en	ru_RU
dc.publisher	Eur. Heart J.	ru_RU
dc.title	Pharmacogenetically determined treatment' influence Left Ventricular Mass Index (LVMI) in relation to polymorphisms of ACE, AGTR1, eNOS, PPAR-G2, ADRB1 genes in essential hypertensive (EAH) patients	ru_RU
dc.type	Other	ru_RU